Form 4 filed by ROTHBLATT MARTINE A
ROTHBLATT MARTINE A filed this Form 4 on UNITED THERAPEUTICS Corp with 26 transaction rows and 5 holding rows, accepted by EDGAR 2026-10-01 21:20:52 UTC.
- Accession
- 0001106578-26-000153
- Filer
- CIK 1106578
- Filed
- 2026-10-01
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: UNITED THERAPEUTICS Corp (CIK 1082554)
- ROTHBLATT MARTINE A director, officer (Chairperson & CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-09-30 | M exercised | +9,500 | $117.76 | 333,943 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -161 | $476.1417 | 333,782 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -749 | $477.4259 | 333,033 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -650 | $478.4676 | 332,383 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -359 | $479.6683 | 332,024 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -601 | $480.7942 | 331,423 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -160 | $482.3575 | 331,263 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -80 | $487.79 | 331,183 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -40 | $495.32 | 331,143 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -40 | $511.37 | 331,103 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -80 | $514.9 | 331,023 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -80 | $517.165 | 330,943 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -80 | $523.36 | 330,863 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -80 | $524.62 | 330,783 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -80 | $526.09 | 330,703 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -160 | $531.11 | 330,543 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -160 | $536.52 | 330,383 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -200 | $537.67 | 330,183 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -40 | $538.65 | 330,143 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -480 | $540.7775 | 329,663 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -580 | $541.7616 | 329,083 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -600 | $543.245 | 328,483 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -840 | $544.048 | 327,643 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -920 | $545.129 | 326,723 | I by Trust |
| Common Stock | 2026-09-30 | S sold | -360 | $546.2322 | 326,363 | I by Trust |
| Common Stock holding | 40,513 | D | ||||
| Common Stock holding | 166 | I by Spouse | ||||
| Common Stock holding | 249,108 | I by Trust | ||||
| Common Stock holding | 45,596 | I by Trust | ||||
| Common Stock holding | 8,902 | I by Trust | ||||
| Stock Option derivative | 2026-09-30 | M exercised | -9,500 | $0 | 328,410 | I by Trust |